Transcriptional regulation of neurogenesis:: potential mechanisms in cerebral ischemia

被引:44
作者
Schoelzke, Marion N. [1 ]
Schwaninger, Markus [1 ]
机构
[1] Heidelberg Univ, Dept Neurol, D-69120 Heidelberg, Germany
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 2007年 / 85卷 / 06期
关键词
transcription; neurogenesis; stroke; cerebral ischemia;
D O I
10.1007/s00109-007-0196-z
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Recent data provides evidence that new neurons are born in cerebral ischemia. Although ultimate evidence for their functional importance is lacking, correlational data suggest that they contribute to recovery. Therefore, the underlying mechanisms of neurogenesis are interesting as a basis for pharmacological enhancement of the phenomenon. Neurogenesis is a multistep process that includes proliferation of precursor cells, migration of the newborn cells to the site of lesion, differentiation, integration into neuronal circuits, and survival. All these steps rely on gene transcription. However, only preliminary data about the specific transcriptional control of neurogenesis in cerebral ischemia have been obtained so far. To promote this investigation, we review currently available information on six pathways (Notch, Wnt/beta-catenin, NF-kappa B, signal transducers and activators of transcription (STA) 3, HIF-1, and cyclic AMP response element-binding protein [CREB]) that have been shown to regulate transcription in neurogenesis and that have been implicated in cerebral ischemia. With the exception of CREB, direct involvement in postischemic neurogenesis is quite conjectural and much more must be learned to draw practical conclusions.
引用
收藏
页码:577 / 588
页数:12
相关论文
共 124 条
[91]   NF-κB is activated and promotes cell death in focal cerebral ischemia [J].
Schneider, A ;
Martin-Villalba, A ;
Weih, F ;
Vogel, J ;
Wirth, T ;
Schwaninger, M .
NATURE MEDICINE, 1999, 5 (05) :554-559
[92]   The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis [J].
Schneider, A ;
Krüger, C ;
Steigleder, T ;
Weber, D ;
Pitzer, C ;
Laage, R ;
Aronowski, J ;
Maurer, MH ;
Gassler, N ;
Mier, W ;
Hasselblatt, M ;
Kollmar, R ;
Schwab, S ;
Sommer, C ;
Bach, A ;
Kuhn, HG ;
Schäbitz, WR .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (08) :2083-2098
[93]   Conditional gene ablation of Stat3 reveals differential signaling requirements for survival of motoneurons during development and after nerve injury in the adult [J].
Schweizer, U ;
Gunnersen, J ;
Karch, C ;
Wiese, S ;
Holtmann, B ;
Takeda, K ;
Akira, S ;
Sendtner, M .
JOURNAL OF CELL BIOLOGY, 2002, 156 (02) :287-297
[94]   Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1 [J].
Semenza, Gregg L. .
EXPERIMENTAL PHYSIOLOGY, 2006, 91 (05) :803-806
[95]   MULTIPLE NUCLEAR FACTORS INTERACT WITH THE IMMUNOGLOBULIN ENHANCER SEQUENCES [J].
SEN, R ;
BALTIMORE, D .
CELL, 1986, 46 (05) :705-716
[96]   Contact-dependent inhibition of cortical neurite growth mediated by notch signaling [J].
Sestan, N ;
Artavanis-Tsakonas, S ;
Rakic, P .
SCIENCE, 1999, 286 (5440) :741-746
[97]   Use of anti-ICAM-1 therapy in ischemic stroke -: Results of the Enlimomab Acute Stroke Trial [J].
Sherman, DG ;
Bes, A ;
Easton, JD ;
Hacke, W ;
Kaste, M ;
Polmar, SH ;
Zivin, JA ;
Fieschi, C ;
Miller, P ;
Schoenfeld, D ;
Street, J ;
Albers, G ;
Atkinson, R ;
Biller, J ;
Bruno, A ;
Carpenter, D ;
Clark, W ;
DeGraba, T ;
Driscoll, P ;
Ellis, J ;
Greenlee, R ;
Hess, D ;
Horowitz, DR ;
Davenport, J ;
Hsu, C ;
Starkman, S ;
Madden, K ;
Pettigrew, C ;
Rosenbaum, D ;
Schim, J ;
Tietjen, G ;
Mansbach, H ;
Edwards, K ;
Webb, R ;
Crisostomo, E ;
Wilterdink, J ;
Rothrock, J ;
Zweifler, R ;
Dexter, J ;
Horowitz, S ;
Futrell, N ;
Alter, M ;
Schneider, D ;
Ferbert, A ;
Hacke, W ;
Prange, H ;
Wiersbitzky, M ;
Büttner, T ;
Schwartz, A ;
Busse, O .
NEUROLOGY, 2001, 57 (08) :1428-1434
[98]   Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells [J].
Shingo, T ;
Sorokan, ST ;
Shimazaki, T ;
Weiss, S .
JOURNAL OF NEUROSCIENCE, 2001, 21 (24) :9733-9743
[99]   PATHOPHYSIOLOGY AND TREATMENT OF FOCAL CEREBRAL-ISCHEMIA .1. PATHOPHYSIOLOGY [J].
SIESJO, BK .
JOURNAL OF NEUROSURGERY, 1992, 77 (02) :169-184
[100]   Activation of NF-kB and ERK1/2 after permanent focal ischemia is abolished by simvastatin treatment [J].
Sironi, L ;
Banfi, C ;
Brioschi, M ;
Gelosa, P ;
Guerrini, U ;
Nobili, E ;
Gianella, A ;
Paoletti, R ;
Tremoli, E ;
Cimino, M .
NEUROBIOLOGY OF DISEASE, 2006, 22 (02) :445-451